A 54-year-old man presented with a very rare case of radiation-induced intramedullary spinal cord anaplastic astrocytoma, which developed 37 years after radiotherapy for testicular seminoma. The patient presented with weakness and numbness of the left lower extremity that had gradually aggravated for 3 months. Magnetic resonance imaging demonstrated an intramedullary mass lesion with syringomyelia at the T9 to T12 levels. Subtotal removal of the tumor was performed using standard microsurgical technique. Histological examination revealed anaplastic astrocytoma. Although radiotherapy was seriously considered, chemotherapy was employed as adjuvant therapy considering the previous treatment. Although his neurological status improved transiently after surgery, relentless neurological decline occurred and resulted in death 9 months following surgery. Considering that subtotal removal of the tumor and chemotherapy had little influence on the quality of life and the length of survival in our case, cordectomy may be the optimum treatment for patients with radiation-induced spinal intramedullary malignant astrocytoma.
Introduction
Radiotherapy has a great value in the treatment of malignant tumors, but also has major side effects such as radionecrosis or oncogenesis. The involvement of radiation in the induction of central nervous system tumors has been documented repeatedly. 14) Such tumors are most frequently meningiomas, 23) sarcomas, 16, 19) and more recently gliomas, especially malignant types. 8) Only eight cases of radiation-induced spinal cord glioma have been reported since the first case in 1980 (Table 1) . 2, 4, 7, 13, 15, 18, 21, 24) Survival is very limited in these cases, regardless of various combinations of surgical resection, radiotherapy, and chemotherapy. Only 2 cases of spinal cord neoplasms have been reported following radiotherapy for testicular seminoma (peripheral nerve sheath tumor and angiosarcoma). 1, 11) Here we describe a case of anaplastic astrocytoma that occurred after radiotherapy for testicular seminoma.
Case Report
A 54-year-old man presented with weakness and numbness of the left lower extremity in August 2009. He visited a local doctor and then was referred to our hospital in November 2009. Neurological examinations revealed mild weakness of the left lower extremity (manual muscle test grade 4/5, mainly quadriceps), reduced sensation in the whole left lower extremity, hyperreflexia of the lower extremities including hyperactive ankle jerks with 5 to 6 beats of unsustained clonus bilaterally, and spastic gait disturbance that forced him to use a cane. There was no remarkable bowel and bladder incontinence. His medical history revealed that he had undergone radiotherapy in 1973 under a diagnosis of testicular seminoma. A total dose of 30.6 Gy had been delivered and the T10-T12 vertebral bodies were included in this treatment.
Magnetic resonance (MR) imaging showed an intramedullary diffuse mass situated between the T9 and T12 vertebral bodies, corresponding to the previous radiation portal (Fig. 1) . The patient underwent laminectomy at T9-T12 and subtotal removal of the lesion, leaving a small portion at the T9 level where the border between the tumor and normal tissue was unclear. Postoperative MR imaging demonstrated almost 90% removal of the tumor (Fig. 2) . Histological examination revealed the cells had morphological resemblance to astrocytes and were immunocytochemically positive for glial fibrillary acidic protein. In addition, the lesion showed high cellularity, hyperchromatic nuclei, high nuclear cytoplasmic ratio, marked cellular atypia and pleomorphism, multinucleated cells, increased number of mitotic figures, abnormal multipolar mitosis, high Ki-67 index (up to 33%), and no necrosis (Fig. 3) . The histological diagnosis was anaplastic astrocytoma. Weakness and reduced sensation of the left lower extremity improved after surgery, although slight and transient neurological deterioration occurred in the right lower extremity after surgery. Then, he moved to another hospital and received oral chemotherapy with temozolomide and physical therapy. Although we seri- 
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Radiation-Induced Spinal Anaplastic Astrocytoma ously considered the indication for radiotherapy, the radiologists finally abandoned this idea considering the site and the dose of the previous radiotherapy. He was readmitted to our hospital in May 2010, because of profound worsening of his neurological status. He complained of bilateral lower extremity weakness and reduced sensations and was confined to a wheelchair. Neurological examination found weakness of manual muscle test grade 1/5 in both lower extremities, reduced sensation over the whole bilateral lower extremities, hyperreflexia of the lower extremities, and bowel and bladder incontinence. The cranial nerves and upper extremities had normal functions. Thoracic MR imaging showed an intramedullary diffuse mass situated between the T3 and T12 vertebral bodies (Fig. 4A, B) . Head MR imaging revealed no remarkable intracranial abnormal intensity on admission (Fig. 4C, D) . Two cycles of chemotherapy using nimustine hydrochloride (Nidran } ; Daiichi Sankyo Co., Ltd., Tokyo) (150 mg) were given, but the patient developed significant neck pain, vomiting, and weakness of the upper extremities. Cervical MR imaging demonstrated expansion of the tumor into the C4 levels (Fig. 5A, B) . After development of hydrocephalus (Fig. 5C) , he was transferred to the palliative care unit and died in August 2010.
Discussion
Four criteria have been proposed for determining if a tumor is radiation-induced neoplasm: the second tumor must arise in the irradiated field; a latent period of several years must have elapsed between radiation exposure and development of a second neoplasm; the tumor diagnosis must be confirmed histopathologically; and the second tumor must be histopathologically distinct from the original tumor. 15, 18) The present case fulfilled all these criteria for a radiation-induced neoplasm, so we conclude that the spinal cord anaplastic astrocytoma in this patient was induced by radiotherapy. In the present case, the second tumor arose after a latency period of 37 years, the longest latency period for a radiation-induced astrocytoma compared to another case after 25 years ( Table 1 ), indicating that radiation-induced spinal cord astrocytoma may occur even several decades after the radiotherapy. In our case, the tumor arose following radiotherapy for testicular seminoma, in which the lower thoracic vertebral bodies are usually included in the radiation field. In four of eight Neurol Med Chir (Tokyo) 52, September, 2012 Y. Kawanabe et al.
reported cases of radiation-induced spinal cord astrocytoma, the tumors arose following treatment for Hodgkin's lymphoma, in which the vertebral bodies were usually included in the radiation field. The cervical vertebral bodies were also affected in the radiotherapy for thyroid carcinoma, nasopharyngeal carcinoma, medullomyoblastoma, and pulmonary tuberculosis. Therefore, we need to pay special attention to the clinical history of these diseases in assessing a case of spinal cord astrocytoma.
Radiation-induced spinal malignant astrocytoma (anaplastic astrocytoma and glioblastoma multiforme) is extremely rare. These tumors are notoriously difficult to treat because total removal of tumor without causing new neurological deficits may be impossible. Moreover, they are relatively resistant to the radiotherapy and chemotherapy, 3, 5, 17) and the effects of immunotherapy and neutron therapy are still unclear. The average survival period in our case and the five reported cases was about 38 weeks, although several therapeutic modalities including radiotherapy and chemotherapy were attempted. On the other hand, the survival times with spinal anaplastic astrocytoma and glioblastoma are around 80 weeks and 75 weeks, respectively. 17) These results indicate that the prognosis of radiation-induced spinal high grade astrocytoma is worse than that of spontaneous spinal high grade astrocytoma. Therefore, we need to carefully check for a past history of radiotherapy preoperatively if spinal high grade astrocytoma is suspected. An initial strategy of biopsy may be more appropriate than attempted resection for a patient with suspected radiation-induced spinal astrocytoma. 7) Cordectomy is advocated as a reasonable alternative treatment for spinal malignant astrocytoma presenting with complete deficit below the lesion, 6, 9, 12) for the treatment of pain, spasticity, and posttraumatic syringomyelia. 10, 20, 22) The effects of cordectomy for spinal malignant astrocytoma with remaining function below the lesion are unknown. To perform cordectomy in such cases, the patients need to accept complete deficits below the lesion and decreased quality of life after cordectomy. However, judging from the results that 90% removal of tumor and chemotherapy had little influence on the quality of life and the length of survival in this case, and the poor outcome reported, cordectomy may be the optimum treatment for radiation-induced spinal cord anaplastic astrocytoma.
